Skip to content

Envoy Medical COCH Debt Issuance Costs

Debt Issuance Costs at other companies

Travel + Leisure logo
Travel + LeisureTNL
$6M+20.0%
HES
Hess MidstreamHESM
$0-100%
Belden logo
BeldenBDC
$8.63M
Donnelley Financial Solutions logo
Donnelley Financial SolutionsDFIN
$0-100%
Oaktree Specialty Lending logo
Oaktree Specialty LendingOCSL
$4.85M+366%
CorMedix logo
CorMedixCRMD
$135K

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfFinancingCosts.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's debt issuance costs?
Envoy Medical (COCH) reported debt issuance costs of $208K in Q1 2026.
How has Envoy Medical's debt issuance costs changed year-over-year?
Envoy Medical's debt issuance costs decreased by 10.7% year-over-year, from $233K to $208K.
What is the long-term trend for Envoy Medical's debt issuance costs?
Over 2 years (2023 to 2025), Envoy Medical's debt issuance costs has grown at a 21.2% compound annual growth rate (CAGR), from $563K to $827K.
What does debt issuance costs mean?
Cash paid for fees, legal costs, and underwriting discounts associated with issuing new debt.